NanoEntek is a global biotech company that pioneered the world’s first automated cell counter. Founded in 2000 in the Seoul metropolitan area, NanoEntek owns over 100 patents in nano- and microfluidic biotechnology, with proprietary "lab-on-chip" platforms serving IVD and Life Sciences markets worldwide. NanoEntek addresses a longstanding gap in cell counting by introducing the world's first high-throughput, fully automated, walk-away cell counter — the EVE HT series. Purpose-built for Cell & Gene Therapy workflows, it supports process development, QC, and manufacturing with accurate, hands-off cell analysis at scale. With the regional operations run from Munich since 2025, NanoEntek Europe is committed to advancing CGT manufacturing in the European market through innovative, reliable cell counting solutions.